show dates: Oct 22-25, 2023
location: Orlando, FL
booth: 2701
Ashland’s team of solvers is looking forward to seeing you at AAPS 2023 PharmSci 360. You will have the opportunity to discover our newest products.
The team will be on hand to discuss the industry’s most complete portfolio of controlled release products that can be designed to meet a variety of release profiles and dosage forms, including functional excipients for parenteral dosage formulations, such as Cavitron™ cyclodextrins for increasing solubility and high purity Vialose™ trehalose dihydrate, an ingredient used to protect and stabilize proteins for biologic medicines.
To address recent industry and marketplace concerns, the Ashland team will be sharing samples of tablets coated with Aquarius™ TF titanium-free coating. Aquarius™ TF film coatings system is one of the fully formulated coatings systems that Ashland offers.When you're ready to formulate, we're ready to work with you. To set up a meeting with us at AAPS, fill out the form below on the right.
at AAPS Ashland will introduce:
Thought Leadership Chalk Talk
date: Tuesday, October 24 at 12:30 pm – 1:15 pm
location: stage 1
presentation title: designing pharmaceutical materials for extrusion enabled continuous manufacturing
overview:
The potential and versatility of twin-screw hot melt extrusion as a central unit process and enabler of continuous manufacturing of oral solid dosage forms is rapidly emerging as a key topic. An essential advantage of this process technology is eliminating the need for water or organic solvents, thus eliminating the often rate-limiting and energy intensive drying step and the associated environmental impact. This talk will focus on critical material attributes and important structure-function relationships and show how these can be deployed to rationally design and select polymeric excipients that are purpose designed for immediate release melt granulation, controlled release, and amorphous dispersion manufacturing via twin screw extrusion.
speaker:
Thomas Dürig PhD
Sr Director, CTO, Ashland Life Sciences
Technical Posters
date|time: Monday, October 23, 2023 10:30 AM – 11:30 AM ET
title: M1030-11-75 The impacts of PLGA’s material characteristics on the performance of PLGA-based implant prepared by hot melt extrusion
authors: Fengyuan Yang, Ryan Stahnke Kamaru Lawal, Cory Mahnen, Patrick Duffy And Thomas Dürig
date|time: Monday, October 23, 2023 2:30 PM – 3:30 PM ET
title: M1430-02-10 Effects of monomer on PLGA based long-acting injectables’ release and stability
authors: Cory Mahnen, Kamaru Lawal, Fengyuan Yang, Patrick Duffy, Thomas Durig
date|time: Tuesday, October 24, 2023 10:30 AM – 11:30 PM ET
title: T1030-12-82. A New HPC-based Melt Granulation binder designed to enable the adoption of Twin Screw Melt Granulation (TSMG)
authors: Quyen Schwing, Teslin Botoy, Ryan Stahnke, Kamaru Lawal, Kapish Karan, Thomas Dürig
date|time: Tuesday, October 24, 2023 11:30 AM – 12:30 PM ET
title: T1130-01-03 Evaluating the Versatility of the New High Molecular Weight HPC in Dual Active Diabetic Controlled Release Dosages
authors: Teslin Botoy, Brian Huebner, Quyen Schwing, Kapish Karan, and Thomas Dürig
date|time: Tuesday, October 24, 2023 1:30 PM – 2:30 PM ET
title: T1330-01-04 Demonstrating the Utility of a New High Molecular Weight HPC To Make Smaller Modified Release Tablets
authors: Teslin Botoy, Brian Huebner, Quyen Schwing, Kapish Karan, and Thomas Dürig
date|time: Tuesday, October 24, 2023 1:30 PM – 2:30 PM ET
title: T1330-02-10 Evaluating the Impact of an Ultra-High Solids Film Coating System on Process Times and Tablet Aesthetics
authors: Kapish Karan, Nadin Ekmekciyan, Robin Meier, Christian Muehlenfeld, Andreas Altmeyer, and Daniel Bexte
date|time: Wednesday, October 25, 2023 12:30 PM – 1:30 PM ET
title: W1230-11-70 Characterization of a new multifunctional disintegrant for continuous manufacturing
authors: Quyen Schwing, Brian Huebner, Kapish Karan, and Thomas Dürig
©, Ashland. All rights reserved.
